QUIXIL DIN 02283980
Health Canada record
| Active ingredient(s) | FIBRINOGEN (HUMAN) 60.0 MG; THROMBIN (HUMAN) 1200 UNIT; CALCIUM CHLORIDE 6.2 MG |
|---|---|
| Dosage form | Kit; Solution |
| Route | Topical |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | B02BC30 COMBINATIONS |
| Original market date | |
| Current status date | 24-Jul-2006 |
| Source | Health Canada DPD |
Establishment licence of the holder
Omrix Biopharmaceuticals Ltd. — licence , not currently licensed, last inspection rating C (2020-02-16).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FIBRINOGEN (HUMAN)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02565099 | FIBRYGA | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Powder For Solution | FIBRINOGEN (HUMAN) 2 G | Approved |
| 02464616 | FIBRYGA | OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H | Powder For Solution | FIBRINOGEN (HUMAN) 1 G | Marketed |
| 02393352 | RIASTAP | CSL BEHRING CANADA INC | Powder For Solution | FIBRINOGEN (HUMAN) 1000 MG | Marketed |
| 02439026 | TACHOSIL | CORZA MEDICAL GMBH | Patch | FIBRINOGEN (HUMAN) 5.5 MG; THROMBIN (HUMAN) 2 UNIT; COLLAGEN 2.1 MG | Approved |
| 02439034 | TACHOSIL | CORZA MEDICAL GMBH | Patch | FIBRINOGEN (HUMAN) 5.5 MG; THROMBIN (HUMAN) 2 UNIT; COLLAGEN 2.1 MG | Approved |
| 02514222 | VISTASEAL | INSTITUTO GRIFOLS S.A. | Solution | FIBRINOGEN (HUMAN) 80 MG; THROMBIN (HUMAN) 500 UNIT | Marketed |
| 02514230 | VISTASEAL | INSTITUTO GRIFOLS S.A. | Solution | FIBRINOGEN (HUMAN) 160 MG; THROMBIN (HUMAN) 1000 UNIT | Marketed |
| 02514249 | VISTASEAL | INSTITUTO GRIFOLS S.A. | Solution | FIBRINOGEN (HUMAN) 240 MG; THROMBIN (HUMAN) 1500 UNIT | Approved |
| 02514257 | VISTASEAL | INSTITUTO GRIFOLS S.A. | Solution | FIBRINOGEN (HUMAN) 400 MG; THROMBIN (HUMAN) 2500 UNIT | Marketed |
| 02348497 | EVICEL | OMRIX BIOPHARMACEUTICALS LTD | Solution; Kit | FIBRINOGEN (HUMAN) 90 MG; THROMBIN (HUMAN) 1200 UNIT | Cancelled Post Market |
| 02439042 | TACHOSIL | CORZA MEDICAL GMBH | Patch | FIBRINOGEN (HUMAN) 5.5 MG; THROMBIN (HUMAN) 2 UNIT; COLLAGEN 2.1 MG | Dormant |
| 01949020 | TISSEEL KIT VH 1.0 | OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H. | Powder For Solution; Liquid | FIBRINOGEN (HUMAN) 110 MG; PLASMAFIBRONECTIN (CIG) 9 MG; PLASMINOGEN 120 MCG; APROTININ (BOVINE) 300 UNIT; THROMBIN (BOVINE) 4 UNIT; THROMBIN (BOVINE) 500 UNIT; CALCIUM CHLORIDE .04 MMOL; PROTEIN 130 MG; ANTIHEMOPHILIC FACTOR (HUMAN) 50 UNIT | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 8164 | 2006-07-24 | New Drug Submission (NDS) |
International API supply for FIBRINOGEN (HUMAN)
0 active FDA Drug Master Files.
Request a quote for QUIXIL